Generated by All in One SEO v4.9.0, this is an llms.txt file, used by LLMs to index the site.

# Matricelf

## Sitemaps

- [XML Sitemap](https://matricelf.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Hello world!](https://matricelf.com/hello-world/) - Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

## Pages

- [Home](https://matricelf.com/)
- [Spinal Cord Injury](https://matricelf.com/solutions/spinal-cord/)
- [Company Profile](https://matricelf.com/investor-relations-2/) - Download Company Deck (Heb) >>
- [Investor Relations](https://matricelf.com/investor-relations/) - Download Company Deck (Heb) >>
- [About us](https://matricelf.com/company/about-us-2/)
- [Contact Us](https://matricelf.com/contact-us/)
- [Pipeline](https://matricelf.com/solutions/future-pipelines/)
- [Articles](https://matricelf.com/articles-videos/articles/)
- [News & Events](https://matricelf.com/news-events/)
- [Accessibility Statement](https://matricelf.com/accessibility-statement/) - ACCESSIBILITY STATEMENT Matricelf invests the utmost efforts and many resources, to provide all of its clients with equal, respectable, accessible and professional services. In accordance with the 1998 Equal Rights for People with Disabilities Law, and the regulations enacted thereunder, a lot of effort and resources are invested, making the necessary accessibility adjustments, which will
- [Scientific Advisory Board](https://matricelf.com/company/advisory-board/)
- [Investors](https://matricelf.com/investors/) - Download Company Deck (Heb) >>
- [Careers](https://matricelf.com/company/careers/)
- [Videos](https://matricelf.com/articles-videos/videos/)
- [Articles & Videos](https://matricelf.com/articles-videos/)
- [Investors](https://matricelf.com/company/investors/)
- [Company](https://matricelf.com/company/)
- [Privacy Policy](https://matricelf.com/privacy-policy/) - Who we areOur website address is: https://matricelf.com.What personal data we collect and why we collect itCommentsWhen visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection.An anonymized string created from your email address (also called
- [Solutions](https://matricelf.com/solutions/)

## News

- [Matricelf initiates IND enabling efficacy study to support first in human spinal cord injury trial](https://matricelf.com/news/matricelf-initiates-efficacy-study/)
- [Receiving Helsinki Committee and Institutional Approval from Loewenstein Medical Center – Advancing Preparation for Matricelf’s First-in-Human Clinical Trial](https://matricelf.com/news/receiving-helsinki-loewenstein/)
- [Matricelf advances toward first in human spinal cord injury trial following successful completion of GLP safety study](https://matricelf.com/news/completion-of-glp-safety-study/)
- [Matricelf initiates GMP manufacturing program, advancing toward first in human spinal cord injury trial](https://matricelf.com/news/matricelf-initiates-gmp-manufacturing/)
- [Matricelf CEO Gil Hakim Featured in TV10 Israel Interview on the Future of Spinal Cord Repair](https://matricelf.com/news/matricelf-ceo-gil-hakim-featured-in-tv10-israel-interview-on-the-future-of-spinal-cord-repair/)
- [Matricelf Featured in CEOCFO Magazine Interview](https://matricelf.com/news/matricelf-featured-in-ceocfo-magazine-interview/)
- [International Recognition – Matricelf Awarded a Grant from the UK-based Walkoncemore](https://matricelf.com/news/matricelf-awarded-a-grant-from-walkoncemore/)
- [Matricelf Named Most Innovative Company of 2026 at Advanced Therapies Week in San Diego](https://matricelf.com/news/atw26-winning/)
- [Matricelf signs agreement with Sheba Medical Center for clinical manufacturing and advancement of clinical program — a key milestone toward first-in-human spinal cord injury trial](https://matricelf.com/news/agreement-sheba/)
- [Final U.S. patent registration for the company’s 3D bioprinting technology, Omentum based scaffold and delivery system](https://matricelf.com/news/final-u-s-patent-registration/)
- [Matricelf Announces Closing of PIPE Financing of Approximately USD 24.8 Million ](https://matricelf.com/news/matricelf-announces-closing-of-pipe-financing-of-approximately-usd-24-8-million/)
- [Congratulations to Prof. Tal Dvir on His Election as a Fellow of the U.S. National Academy of Inventors](https://matricelf.com/news/academy-of-inventors/)
- [Tune in to watch Matricelf's VP R&D, Dr. Tamar Harel Adar, interviewed on Channel 10](https://matricelf.com/news/tune-in-to-watch-matricelfs-vp-rd-dr-tamar-harel-adar-interviewed-on-channel-10/)
- [Matricelf signs agreement with the Institute for Advanced Cellular Therapies (I-ACT) at Tel Aviv Sourasky Medical Center (Ichilov) for clinical manufacturing — a significant milestone towards the world’s first clinical trial for spinal cord injury treatment](https://matricelf.com/news/matricelf-signs-agreement-with-the-institute-for-advanced-cellular-therapies-i-act/)
- [Appointment of Ron Mayron to the Company’s Board of Directors](https://matricelf.com/news/appointment-of-ron-miron/)
- [Patent allowance in the U.S. for the company’s 3D printing technology – omentum-based scaffold and delivery system](https://matricelf.com/news/patent-allowance-in-the-u-s/)
- [Matricelf's CEO, Gil Hakim, interviewed at 'Today's Talk' (Channel 13) about potential cure for paralysis](https://matricelf.com/news/matricelfs-ceo-gil-hakim-interviewed-at-todays-talk-channel-13-about-potential-cure-for-paralysis/)
- [Blue-and-white breakthrough: Israel to perform first-ever transplant of lab-grown spinal cord (Ynet)](https://matricelf.com/news/blue-and-white-breakthrough-israel-to-perform-first-ever-transplant/)
- [World's first spinal cord transplant to take place in Israel, could allow patients to walk again](https://matricelf.com/news/worlds-first-spinal-cord-transplant-to-take-place-in-israel-could-allow-patients-to-walk-again/)
- [Matricelf featured on Channel 12's primetime news](https://matricelf.com/news/matricelfs-ceo-gil-hakim-interviewed-at-channel-12-news-about-potential-cure-for-paralysis/)
- [Matricelf to Present at Premier 2025 Spinal Cord Injury Conference](https://matricelf.com/news/matricelf-to-present-at-premier-2025-spinal-cord-injury-conference/)
- [Formation of Clinical Advisory Board to accelerate First-in-Human trial strategy](https://matricelf.com/news/formation-of-clinical-advisory-board/)
- [Approval by the Helsinki Committee and launch of activity in the field of 3D printing of autologous human tissues for medical applications](https://matricelf.com/news/approval-by-the-helsinki-committee/)
- [Success in Rat Study – Final Results of Efficacy Evaluation](https://matricelf.com/news/success-in-rat-study-final-results-of-efficacy-evaluation/)
- [Patent registration in the U.S. for the company’s technology – particles based on unique omentum tissue for therapeutic applications](https://matricelf.com/news/patent-registration-in-the-u-s/)
- [Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments](https://matricelf.com/news/cellino-and-matricelf-announce-global-collaboration/)
- [Final Approval by the U.S. Patent Office – Patent for 3D Bioprinting of Tissues and Organs](https://matricelf.com/news/final-approval-by-the-u-s-patent-office-patent-for-3d-bioprinting-of-tissues-and-organs/)
- [Initiation of Comprehensive GLP Animal Safety Study for Engineered Neural Tissue to Treat Spinal Cord Injuries – A Key Milestone Toward FDA-Compliant Human Clinical Trial](https://matricelf.com/news/initiation-of-comprehensive-glp-animal-safety-study/)
- [Successful Proof of Concept (POC) for Generating Engineered Neural Tissues from Stem Cells Using AI-Based Technology from U.S. Biotech Company Cellino](https://matricelf.com/news/successful-proof-of-concept-cellino/)
- [Successful Safety Results – Preclinical Study in Rats](https://matricelf.com/news/successful-safety-results-preclinical-study-in-rats/)
- [Preliminary Agreements with the Ministry of Health for Use of the Company’s Product Under a Compassionate Use Program](https://matricelf.com/news/preliminary-agreements-compassionate-use-program/)
- [Receiving approval from the Helsinki Committee of Sheba Tel Hashomer Medical Center - First step towards compassionate treatment of spinal cord injuries](https://matricelf.com/news/receiving-approval-from-the-helsinki-committee-of-sheba-tel-hashomer/)

## Videos

- [2019](https://matricelf.com/video/2019/)
- [2019](https://matricelf.com/video/2019-2/)
- [2019](https://matricelf.com/video/2019-3/)
- [2019](https://matricelf.com/video/2019-4/)

## Articles

- [Regenerating the Injured Spinal Cord at the Chronic Phase by Engineered iPSCs-Derived 3D Neuronal Networks](https://matricelf.com/articles/regenerating-the-injured-spinal-cord-at-the-chronic-phase-by-engineered-ipscs-derived-3d-neuronal-networks/)
- [Omentum ECM-based hydrogel as a platform for cardiac cell delivery](https://matricelf.com/articles/omentum-ecm-based-hydrogel-as-a-platform-for-cardiac-cell-delivery/)
- [Optimizing the biofabrication process of omentum-based scaffolds for engineering autologous tissues](https://matricelf.com/articles/optimizing-the-biofabrication-process-of-omentum-based-scaffolds-for-engineering-autologous-tissues/)
- [A Stretchable and Flexible Cardiac Tissue–Electronics Hybrid Enabling Multiple Drug Release, Sensing, and Stimulation](https://matricelf.com/articles/a-stretchable-and-flexible-cardiac-tissue-electronics-hybrid-enabling-multiple-drug-release-sensing-and-stimulation/)
- [Electrical Conductivity, Selective Adhesion, and Biocompatibility in Bacteria-Inspired Peptide–Metal Self-Supporting Nanocomposites](https://matricelf.com/articles/electrical-conductivity-selective-adhesion-and-biocompatibility-in-bacteria-inspired-peptide-metal-self-supporting-nanocomposites/)
- [Fabrication of omentum-based matrix for engineering vascularized cardiac tissues](https://matricelf.com/articles/fabrication-of-omentum-based-matrix-for-engineering-vascularized-cardiac-tissues/)
- [Multifunctional degradable electronic scaffolds for cardiac tissue engineering](https://matricelf.com/articles/multifunctional-degradable-electronic-scaffolds-for-cardiac-tissue-engineering/)
- [3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts](https://matricelf.com/articles/3d-printing-of-personalized-thick-and-perfusable-cardiac-patches-and-hearts-2/)
- [ECM-based macroporous sponges release essential factors to support the growth of hematopoietic cells](https://matricelf.com/articles/ecm-based-macroporous-sponges-release-essential-factors-to-support-the-growth-of-hematopoietic-cells/)
- [Personalized Hydrogels for Engineering Diverse Fully Autologous Tissue Implants](https://matricelf.com/articles/personalized-hydrogels-for-engineering-diverse-fully-autologous-tissue-implants/)
- [Channeled ECM-Based Nanofibrous Hydrogel for Engineering Vascularized Cardiac Tissues](https://matricelf.com/articles/channeled-ecm-based-nanofibrous-hydrogel-for-engineering-vascularized-cardiac-tissues/)

## Team members

- [Dr. Adam Wollowick, M.D.](https://matricelf.com/team_member/brock-reeve/) - Dr Wollowick is the Sr. Director of Business Development at Stryker Spine. At Stryker, Adam is focusing on mergers and acquisitions and also has responsibility for the Spine Division’s Strategy and Business Intelligence functions. Dr. Wollowick is board-­certified by the American Board of Orthopedic Surgery. He is a member of the American Academy of Orthopedic
- [Prof. Mark Tuszynski, M.D.](https://matricelf.com/team_member/prof-mark-tuszynski/) - Prof. Mark Tuszynski, a world-renowned neurologist and researcher, is the Director of The Center for Neural Repair, University of California, San Diego. Mark is considered a leading researcher in the field of spinal cord injury treatment and his laboratory focuses on research in the field of neuronal regeneration in general and spinal cord injuries in
- [Dr. Moshe Bondi, M.D.](https://matricelf.com/team_member/dr-moshe-bondi-md/) - Dr. Moshe Bondi is Director of the Department of Neurological Rehabilitation and Head of Neurological Rehabilitation Outpatient Services at Sheba Medical Center, one of the world’s leading hospitals. A specialist in Physical Medicine and Rehabilitation (PM&R), he focuses on spinal cord injury (SCI) and pain rehabilitation, with expertise in managing secondary complications in individuals with
- [Prof. Nicholas Theodore, M.D.](https://matricelf.com/team_member/dr-nicholas-theodore-m-d/) - Dr. Theodore is a Professor of Neurosurgery and the director of the Johns Hopkins Neurosurgical Spine Center. He is one of the world recognized expert in brain and spinal cord injury, minimally invasive spine surgeries and robotics. Dr. Theodore has written or co-authored 30 book chapters, over 180 peer-reviewed journal articles and is co-holder of
- [Prof. James S. Harrop, M.D., FACS](https://matricelf.com/team_member/prof-james-s-harrop-m-d-facs/) - Dr. James S. Harrop is a Professor of Neurological Surgery at Thomas Jefferson University and Chief of the Division of Spine and Peripheral Nerve Surgery at Thomas Jefferson University Hospital. Internationally recognized as a leading expert in spinal cord injury, spinal trauma and complex spine surgery, Dr. Harrop has dedicated his career to advancing the
- [Prof. Ran Harel, M.D.](https://matricelf.com/team_member/prof-ran-harel-m-d/) - Prof. Harel is Director of the Spine Surgery and Spine Radiosurgery Division at Sheba Medical Center, one of the world’s top-ranked hospitals. He is an expert in minimally invasive spine surgery, spinal oncology, and radiosurgery, and was named among Israel’s top spine surgeons by Forbes magazine. Trained at Sheba and the Cleveland Clinic, Prof. Harel
- [Meir Clifi-Amir; Maj, Gen. (Res.)](https://matricelf.com/team_member/meir-clifi-amir-maj-gen-res/) - Meir Clifi Amir is a senior military leader and executive with broad experience in strategic leadership, national level decision making, and complex organizational management. He served in several high ranking IDF roles, including Military Secretary to the Prime Minister, and brings expertise in risk management, regulatory environments, and government relations.
- [Tamar Harel Adar, PhD – CTO](https://matricelf.com/team_member/tamar-harel-adar-phd-vp-rd/) - An expert in biotechnology with experience at CollPlant (NASDAQ: CLGN) and Cellect (NASDAQ: APOP). She holds a Ph.D. in Biotechnology Engineering from Ben-Gurion University. Member of the 'Best Practice Task Force' focused on the standardization of iPSC-based therapy, led by ISSCR (International Society for Stem Cell Medicine)
- [Ron Mayron - Chairman of the Board](https://matricelf.com/team_member/ron-mayron-chairman-of-the-board/) - Mr. Mayron brings with him decades of extensive experience in the biomedical industry in Israel and abroad, including proven expertise in leading international companies, managing complex organizations, formulating growth strategies, business development, and entering new markets. His senior positions at Teva, and particularly his tenure as CEO of Teva Israel, position him as one of
- [Gil Hakim, CEO](https://matricelf.com/team_member/gil-hakim-ceo/) - With over 20 years of experience in life sciences, specializing in early-stage innovation and market strategy. Previously with Urogen Pharma (NASDAQ: URGN), he holds a B.Sc. in Life Sciences from Ben-Gurion University.
- [Dr. Ruchi Sharma, PhD](https://matricelf.com/team_member/dr-ruchi-sharmaת-phd/) - Dr. Ruchi Sharma, Senior Researcher at the National Institutes of Health (NIH), an expert in the manufacturing of induced pluripotent stem cells (iPSCs) in regenerative medicine and the development of cellular therapies.
- [Prof. Michael G. Fehlings, M.D., PhD](https://matricelf.com/team_member/dr-michael-g-fehlings-m-d-ph-d/) - Dr. Michael G. Fehlings is a Professor of Neurosurgery at the University of Toronto and Vice Chair of Research in the Department of Surgery. He serves as a Neurosurgeon at Toronto Western Hospital and holds the Robert Campeau Foundation / Dr. C.H. Tator Chair in Brain and Spinal Cord Research at the University Health Network.
- [Prof. Allan D. Levi, M.D., PhD](https://matricelf.com/team_member/prof-allan-d-levi-m-d-ph-d/) - Dr. Allan D. Levi is Professor and Chair of Neurosurgery at the University of Miami Miller School of Medicine and Chief of Neurosurgery at Jackson Memorial Hospital. He also holds appointments in Orthopaedics and Rehabilitation Medicine and serves as the Chairman of the University of Miami Medical Group. Dr. Levi is an internationally recognized expert
- [Lori Confino](https://matricelf.com/team_member/lori-confino/) - Lori Confino is a well-known and highly respected attorney in the hi-tech and biotech industries. Maintaining a clear view of all the shades and nuances that make up this complex world, Lori brings practical business sense to corporate and commercial transactions. Lori has over three decades of experience in corporate and commercial transactions with an
- [Hadas Shoham Nissan, Director Clinical and Regulatory affairs](https://matricelf.com/team_member/hadas-shoham-nissan/) - With over 15 years of experience in cell and gene therapy, spanning clinical, regulatory, and business aspects. Previously with Emendo and Gamida Cell (NASDAQ: GMDA), she holds an M.Sc. in Medical Research and an M.B.A. in Finance & Marketing from the Hebrew University.
- [Anat Shnaiderman, QA Manager](https://matricelf.com/team_member/anat-shnaiderman/) - Brings over 15 years of QA and GMP experience in cell therapy and biologics. Previously held roles at BrainStorm Cell Therapeutics (NASDAQ: BCLI), Teva Pharmaceuticals (NYSE: TEVA), and Cognate BioServices (acquired by Charles River Laboratories, NYSE: CRL). She holds an M.Sc. in Medical Sciences and a B.Sc. in Biology from Tel Aviv University.
- [Suzana Nahum-Zilberberg](https://matricelf.com/team_member/prof-rivka-carmi-2/) - Suzana Nahum-Zilberberg is a seasoned executive with a vast managerial and leadership experience in the healthcare industry across global companies and early-stage companies. With financial expertise and experience as a board member in various companies. Ms. Nahum-Zilberberg is a strategic advisor and the Chairman of The Activity Based Therapy (ABT) Center Foundation for Neurorehabilitation. She served
- [Doron Birger  – Chairman of the Board](https://matricelf.com/team_member/doron-birger-chairman-of-the-board/) - Doron serves as the chairman and a director in a variety of technology companies, mainly in medical device companies. In the past, Doron served as the CEO of Elron (Nasdaq: ELRNF, TASE: ELRN) and as the chairman and director of Given Imaging (previously traded at Nasdaq: GIVN; TASE: GIVN) until it was sold to Covidien
- [Alon Sinai, PhD – Co-Founder, Deputy CEO & President](https://matricelf.com/team_member/alon-sinai-founder-ceo/) - With over 25 years of experience in medical operations and biotech, previously with LBT Laser Beam Therapeutics, he holds a Ph.D. in Health Systems Management from Ben-Gurion University.
- [Prof. Tal Dvir, PhD – Co-Founder & CSO](https://matricelf.com/team_member/tal-dvir-phd-cso/) - A pioneer in regenerative medicine, trained at MIT under Prof. Robert Langer. He founded Tel Aviv University’s Tissue Engineering Lab and leads research in nanotechnology-based tissue regeneration. An award-winning researcher and recipient of the Young and Promising Bio-Medical Researcher Rappaport Prize (2018), the Juludan Foundation Research Award (2018), and the Da Vinci Award (2023).
- [Tal Ben Neriah, VP Operations](https://matricelf.com/team_member/tal-ben-neriah-director-of-operations-2/) - A leader in biotechnology operations with expertise in regenerative medicine and product development. Previously with CollPlant (NASDAQ: CLGN), she holds an M.Sc. in Materials Engineering & Nanotechnology from Tel Aviv University.
- [Sigal Russo, CFO](https://matricelf.com/team_member/sigal-russo/) - With over 16 years of financial experience in biotech and pharmaceuticals. Previously with OWC Pharma (OTCQB: OWCP) and Rosetta Genomics (NASDAQ: ROSG), she holds a B.A. in Economics and Accounting from Ruppin Academic College.
- [Brock Reeve](https://matricelf.com/team_member/brock-reeve-2/) - Brock Reeve has been the Executive Director of the Harvard Stem Cell Institute since 2006. The Institute invests in research at Harvard and its hospitals with the goal of developing new curative medicines. Brock is also the CEO of IVIVA Medical, a startup company focused on organ regeneration. He is a co-founder of Elevian, a
- [Prof. Ruth Arnon](https://matricelf.com/team_member/prof-ruth-arnon-2/) - Prof. Ruth Arnon Formerly Vice-President of the Weizmann Institute of Science (1988-1997), Professor Arnon is an internationally known immunologist. Along with Prof. Michael Sela, she conceptualized and developed Copaxone®, a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration and is presently marketed worldwide. Prof. Arnon has
- [Eckhard von Keutz, PhD](https://matricelf.com/team_member/eckhard-von-keutz/) - Dr Von Keutz is the Chairman of the Advisory Board of the Fraunhofer Institute of Toxicology and Experimental Medicine (Hannover, Germany); Member of the Executive Council at Center of Healthcare Innovation (US); Member of the Advisory Committee for Pharmacologically Active Substances and Veterinary Drugs of the German Federal Institute for Risk Assessment; Member of the
- [Stanley Hirsch](https://matricelf.com/team_member/ori-hershkovits/) - Stanley Hirsch is a biotech and pharma CEO and Board Director with significant experience across biopharmaceutical and agricultural biotech fields. He has extensive executive and board level experience in private and publicly listed companies on US and UK exchanges, direct experience raising capital and leading Mergers & Acquisitions.
- [Neomi Enoch](https://matricelf.com/team_member/neomi-enoch/) - Neomi Enoch, CPA, MBA Neomi is a business consultant, bringing a vast experience as a CFO in global companies traded at NASDAQ and Tel Aviv stock exchange. Neomi led the IPO of Parter communication at NASDAQ, and The IPO of Mul-T-Lock in Tel Aviv Stock Exchange and raised funds from capital market as CFO of

## Categories

- [Uncategorized](https://matricelf.com/category/uncategorized/)

## Team Member Categories

- [Board of Directors](https://matricelf.com/team_member_cat/board-of-directors/)
- [Scientific Advisory Board](https://matricelf.com/team_member_cat/advisory-board/)
- [Team](https://matricelf.com/team_member_cat/team/)
- [Clinical Advisory Board](https://matricelf.com/team_member_cat/clinical-advisory-board/)